oral medium-chain triglycerides were given to 10 normal volunteers , 12 cirrhotics ( group i ) without and 28 cirrhotics ( group ii ) with abnormal portal systemic communications ( ascites , splenomegaly , oesophageal varices , or surgically-created portacaval shunts ) .
C0724624
medium-chain triglycerides
C0003962
ascites